https://orcid.org/0000-0003-0037-0303
References
- Bergerot PG, Bergerot CD, Philip EJ. Emotional distress during the COVID-19 pandemic: psycho-oncology perspective. Oncology. 2020; 34(7):270–1.
- Papautsky EL, Hamlish T. Emotional response of US Breast Cancer Survivors During the COVID-19 Pandemic. Cancer Investigation. 2020. doi:10.1080/07357907.2020.1841220.
- Sigorski D, Sobczuk P, Osmola M, Kuć K, Walerzak A, Wilk M, et al. Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy. ESMO Open. 2020;5(5):e000970. doi:10.1136/esmoopen-2020-000970
- Chen G, Wu Q, Jiang H, Zhang H, Peng J, Hu J, et al. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID‐19. Psycho‐Oncol. 2020;29(9):1395–1398. doi:10.1002/pon.5451
- Prevention, C. F. D. C. A. Interim guidance for healthcare facilities: preparing for community transmission of COVID-19 in the United States. In: Coronavirus Disease 2019 (COVID-19). Atlanta (GA): Communicable Disease Control; 2020.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239–1242. doi:10.1001/jama.2020.2648.
- Schellekens MPJ, Lee ML. Loneliness and belonging: exploring experiences with the COVID‐19 pandemic in psycho‐oncology. Psycho‐Oncol. 2020;29(9):1399–1401. doi:10.1002/pon.5459
- Staehler M, Battle D, Pal SK, Bergerot CD. Counterbalancing COVID-19 with cancer surveillance and therapy: a survey of patients with renal cell carcinoma. Eur Urol Focus. 2020:S2405-4569(20)30259-5.. doi:10.1016/j.euf.2020.09.002.